ISSN: 2165-7904

Journal of Obesity & Weight Loss Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Perspective Article   
  • J Obes Weight Loss Ther 2022, Vol 12(9): 519
  • DOI: 10.4172/2165-7904.1000519

Microbiome Discovery May Open New Doors to Development of Treatments for Gastrointestinal Diseases

Pushkar K*
Department of Health and science education, India
*Corresponding Author: Pushkar K, Department of Health and science education, India, Email: puahkar_K@gmail.com

Received: 01-Sep-2022 / Manuscript No. JOWT-22-519 / Editor assigned: 03-Sep-2022 / PreQC No. JOWT-22-519 (PQ) / Reviewed: 19-Sep-2022 / QC No. JOWT-22-519 / Revised: 23-Sep-2022 / Manuscript No. JOWT-22-519 (R) / Published Date: 29-Sep-2022 DOI: 10.4172/2165-7904.1000519

Introduction

University of Calgary researchers probing the gut - the inner tube of life - have for the first time discovered specific factors in its workings that in the future may help improve treatment for patients facing gut damage or gastrointestinal disease.

The findings from Snyder Institute for Chronic Diseases researchers immediately improve the understanding of factors that help regulate the enteric nervous system, the system of nerves that control the gastrointestinal tract [1]. Researchers can now explore novel ways to treat gastrointestinal disorders using approaches based on these new findings, though the transition to treatment is likely years away.

About the Study

The study's findings may impact future treatments for gastrointestinal diseases and disorders such as irritable bowel syndrome, inflammatory bowel disease and slow transit constipation, among others.

We have uncovered microbial factors that help regulate the function and structural integrity of the enteric nervous system. These and other gastrointestinal diseases with manifested changes in enteric neural control are all hard to treat [2]. Our findings could impact approaches to their treatment.

Be aware, though, that there is a big jump from mice to men. In other words, translating our findings will be important, and our results are in only at the starting point of this journey.

The study examined the effects of microbiome depletion and restoration in animal models using approaches that cause structural and functional changes in the gut [3]. The researchers discovered that while microbiome depletion caused a loss of neurons, natural microbiome recovery restored gut function and promoted the growth of new neurons.

The findings from our work provide clues as to the mechanisms that control 'plasticity' or the ability of the gut nervous system to be repaired if it undergoes damage. The most challenging aspect of researching the unknown physiological roles of the intestinal microbiota lies in identifying specific microbial-derived molecules that may affect the host, as there is a myriad of molecules with the potential to do so [4, 5]. The research team able to hypothesize and demonstrate a link for two different bacterial molecules involved in the regulation of neuronal integrity.

Conclusion

This research was exciting in that it allowed him to collaborate with a great team of people who contributed the complementary expertise needed to test these novel hypotheses. The research team include exploring other potential microbial factors and their role in the neural control of the gut.

There is a rising awareness among the public through discussions in social media, on the internet and even through promotion of products such as yogurts that contain probiotics, that the gut microbiome plays a vital role in health as well as disease. These conversations are making their way into physicians' offices.

As our understanding increases regarding the role the gut microbiome plays in gut health, I think we will ultimately have new ways to diagnose and treat gastrointestinal diseases on an individual level.

References

  1. Berg G (2016) Analysing the plant microbiome for control of pathogens. Recent trends in PGPR research for sustainable crop productivity 45.
  2. Google Scholar

  3. Compare D, Nardone G (2011) Contribution of gut microbiota to colonic and extracolonic cancer development. Dig Dis 29: 554-561.
  4. Indexed at, Google Scholar, Crossref

  5. Zhang X, Li L, Butcher J, Stintzi A, Figeys D (2019) Advancing functional and translational microbiome research using meta-omics approaches. Microbiome 7: 1-12.
  6. Indexed at, Google Scholar, Crossref

  7. Shilaih M, Angst DC, Marzel A, Bonhoeffer S, Günthard HF, et al. (2018) Antibacterial effects of antiretrovirals, potential implications for microbiome studies in HIV.
  8. Indexed at, Google Scholar, Crossref

  9. Lemon KP, Armitage GC, Relman DA, Fischbach MA (2012) Microbiota-targeted therapies: an ecological perspective. Sci Transl Med 4: 137rv5-137rv5.
  10. Indexed at, Google Scholar, Crossref

Citation: Pushkar K (2022) Microbiome Discovery May Open New Doors to Development of Treatments for Gastrointestinal Diseases. J Obes Weight Loss Ther 12: 519. DOI: 10.4172/2165-7904.1000519

Copyright: 2022 Pushkar K. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top